Traws Pharma, Inc. Common Stock (TRAW) is a publicly traded Healthcare sector company. As of October 24, 2026, TRAW trades at $0.36 with a market cap of $5.64M and a P/E ratio of 0.57. TRAW moved -6.79% today. Year to date, TRAW is -73.45%; over the trailing twelve months it is -86.98%. Its 52-week range spans $0.33 to $3.27. Analyst consensus is neutral with an average price target of $1.00. Rallies surfaces TRAW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest TRAW news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $0.36 |
| Market Cap | $5.64M |
| P/E Ratio | 0.57 |
| EPS | $0.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.27 |
| 52-Week Low | $0.33 |
| Volume | 105.35K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.79M |
| Net Income | $9.17M |
| Gross Margin | 0.00% |
1 analysts cover TRAW: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $1.00.